Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1972 Mar;10(3):409–416.

Detection of Australia antigen by biological assay in `Au negative' kidney homograft recipients with hepatic dysfunction

M Torisu, T Yokoyama, A L Durst, G Schroter, C W Putnam, C G Halgrimson, T E Starzl
PMCID: PMC1713164  PMID: 4624497

Abstract

Rabbits were immunized with the sera from patients with known Au antigenaemia; from kidney homograft recipients who were Au negative with direct conventional tests but who had hepatic dysfunction; and from normal volunteers. Heterologous anti-Au antibodies were raised by the first of these kinds of sera but not by the third. Sera from seven of the eleven immunosuppressed kidney recipients of the second group did not raise anti-Au antibodies in the rabbit, but sera from the other four did. The results indicate that the Au antigen may be present in trace quantities in significant numbers of immunosuppressed patients previously thought to be Au negative. However, they do not unequivocally establish an aetiologic association between Au antigenaemia and `post-transplantation liver disease', probably because of the obscuring and important factor of hepatotoxicity of the immunosuppressive agents.

Full text

PDF
409

Images in this article

414Fig. 1
on p.414
415Fig. 2
on p.415

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUSSARD A. [Description of a technic simultaneously combining electrophoresis and immunological precipitation in gel: electrosyneresis]. Biochim Biophys Acta. 1959 Jul;34:258–260. doi: 10.1016/0006-3002(59)90261-6. [DOI] [PubMed] [Google Scholar]
  2. Bulkley B. H., Goldfinger S. E., Heizer W. D., Isselbacher K. J., Shulman N. R. Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet. 1970 Dec 26;2(7687):1323–1326. doi: 10.1016/s0140-6736(70)92356-1. [DOI] [PubMed] [Google Scholar]
  3. Prince A. M., Burke K. Serum hepatitis antigen (SH): rapid detection by high voltage immunoelectroosmophoresis. Science. 1970 Aug 7;169(3945):593–595. doi: 10.1126/science.169.3945.593. [DOI] [PubMed] [Google Scholar]
  4. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  5. Shulman N. R., Barker L. F. Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science. 1969 Jul 18;165(3890):304–306. doi: 10.1126/science.165.3890.304. [DOI] [PubMed] [Google Scholar]
  6. Starzl T. E., Halgrimson C. G., Penn I., Martineau G., Schroter G., Amemiya H., Putnam C. W., Groth C. G. Cyclophosphamide and human organ transplantation. Lancet. 1971 Jul 10;2(7715):70–74. doi: 10.1016/s0140-6736(71)92046-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Torisu M., Yokoyama T., Amemiya H., Kohler P. F., Schroter G., Martineau G., Penn I., Palmer W., Halgrimson C. G., Putnam C. W. Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen. Ann Surg. 1971 Oct;174(4):620–639. doi: 10.1097/00000658-197110000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Vischer T. L. Australia antigen and autoantibodies in chronic hepatitis. Br Med J. 1970 Jun 20;2(5711):695–698. doi: 10.1136/bmj.2.5711.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Vyas G. N., Shulman N. R. Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science. 1970 Oct 16;170(3955):332–333. doi: 10.1126/science.170.3955.332. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES